Sanara Medtech Inc (NASDAQ: SMTI) stock closed at $31.20 on 3/25/25 after a major decline of -12.6%. Moreover, exceptionally high trading volume at 293% of normal accompanied the decline. The stock has been strong relative to the market over the last nine months but has declined -5.2% during the last week.
Current PriceTarget Research Rating
Sanara Medtech has a current Value Trend Rating of D (Negative). The Value Trend Rating reflects very contradictory signals from PTR’s two proprietary measures of a stock’s attractiveness. Sanara Medtech has a very low Appreciation Score of 7 but a slightly positive Power Rating of 69, producing the Negative Value Trend Rating.
Rating Review
In light of this highly negative price change we are reviewing our current Overall Rating of D. This review will be completed in the next several days.
Be the first to comment